Clinical trial
Standardized Goal-Directed vs. Self-Directed Valsalva Maneuver for the Assessment of Patent Foramen Ovale
NCT06670781 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Standardized Goal-Directed vs. Self-Directed Valsalva Maneuver for the Assessment of Patent Foramen Ovale
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 30, 2025
- Completion date
- October 31, 2026
- Enrollment
- 488 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.